Illuminate is organised and funded by GSK, intended for UK HCPs and other relevant decision makers. This site contains promotional information.
Inhale is organised and funded by GSK, intended for UK HCPs and contains promotional information.
March 2026 | NP-GB-CEP-WCNT-260002
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
To stay up to date with the latest peer-led, practical resources designed to support your professional development and the implementation of immunisation programmes, please register.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminate
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
To stay up to date with the latest peer-led, practical resources designed to support your professional development and the implementation of immunisation programmes, please register.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminate
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Plan dedicated shingles clinics during Shingles Awareness Week
Send additional invites or reminders during Shingles Awareness Week
Practical resources & webinars designed to support your programme implementation
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
For UK healthcare professionals — information and support on healthcare challenges and primary care issues
Important notice: This content is intended for UK healthcare professionals.
By entering this site, you are confirming you are a UK healthcare professional. The HCP Clinical Hub section of this site contains promotional information.
If you are not a healthcare professional, please select ‘I’m a member of the UK public’.
You are now leaving this GSK website to visit a third-party website that is not owned or controlled by GSK. GSK does not recommend, endorse or accept liability for websites controlled by third-parties.
This content is for UK healthcare professionals only. If you have already registered, enter your email address below to log in.
Not registered? Register now to access this content.
Organised and funded by GSK. For UK healthcare professionals only. This site contains promotional material.
For UK healthcare professionals – this site contains promotional information.
Important notice: This site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.
This site is intended for members of the UK public, patients and their carers.
Organised and funded by GSK. For UK healthcare professionals only. This site contains promotional material.
For UK healthcare professionals – This section of the site contains promotional information. Please confirm you understand this by clicking the button below.
Important notice: This site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Organise & implement dedicated clinics
Highlight the schedule consists of two-doses
Engage with illuminate’s practical resources
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Organise & implement dedicated clinics
Highlight the schedule consists of two-doses
Engage with illuminate’s practical resources
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Support your understanding of the Shingles National Immunisation Programme criteria
Simplify the planning and implementation of vaccination clinics
Learn from your peers and drive immunisation best practice
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Plan and Implement dedicated Shingles clinics
Identify and proactively recall first and second dose patients for the shingles vaccination
Engage with practical resources, like Patient Support Materials, on Illuminate
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
Organised and funded by GSK. For UK healthcare professionals only. This site contains promotional material.
For UK healthcare professionals — This section of the site contains promotional information
Important notice: This site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.
This site is intended for members of the UK public, patients and their carers.
November 2024 | NP-GB-FVU-WCNT-240001
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Plan dedicated shingles clinics during Shingles Awareness Week
Send additional invites or reminders during Shingles Awareness Week
Practical resources & webinars designed to support your programme implementation
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
To stay up to date with upcoming COPD resources to support your professional development and the implementation of behaviour change principles in your practice, please register.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI Trelegy Ellipta® (fluticasone furoate/umeclidinium/vilanterol) prescribing information Click here.
We will be in touch when more resources for you are added to inhale.
Go back to exploring inhaleNovember 2024 | PM-GB-CPU-WCNT-240019
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
32.6%
Of the estimated 158,166 adults who turned 65 between 1st Sept 2023 and 30th Nov 2023 had received their first dose by 23rd July 2024
43.0%
Of the estimated 128,220 adults who turned 70 between 1st Sept 2023 and 30th Nov 2023 had received their first dose by 23rd July 2024
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.